ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,248.49
-0.86%
Dow Jones
42,047.40
-1.38%
Gold vs US Dollar
2,685.57
0.57%
Brent Oil
79.19
2.94%
Bitcoin
94,816.53
2.60%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Italy
  5. BIT

  6. Sanofi (1SAN) Share Price

1SAN Sanofi

95.60
-0.98 (-1.01%)
10 Jan 2025 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Sanofi BIT:1SAN Italian Stock Exchange Ordinary Share FR0000120578 
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.98 -1.01 95.60 94.68 97.70 96.12 95.60 96 584 16:30:18   
 Type  Size  Price  Time  Units 
  60 95.60 16:12:04 EUR
 
Recent News
DateTimeSource
HeadlineMore 1SAN News
09/01/202506:00UKREGCommuniqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a satisfait aux co-critères d’évaluation primaires de l’étude de phase III IRAKLIA dans le myélome multiple
09/01/202506:00UKREGPress Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma
23/12/202406:00UKREGCommuniqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de développer une nouvelle génération de vaccins pneumococciques conjugués
23/12/202406:00UKREGPress Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines
19/12/202417:00UKREGPresse release: Jean-Paul Kress to join Sanofi's Board of Directors
19/12/202417:00UKREGCommuniqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi
17/12/202412:30UKREGPress Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease
Period
Draw mode
Data Downloads for 1SAN

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Sanofi Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads